Monitoring environmental factors affecting skin diseases using non-invasive methods
Exposome Monitoring for Skin Diseases through Liquid Biopsy Multiomics
This study is looking at how things in our environment affect skin conditions like psoriasis and atopic dermatitis, and it’s designed for patients who want to better understand their skin health by tracking changes in real-time from home.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11080629 on NIH RePORTER |
What this research studies
This research investigates how environmental factors influence skin diseases like psoriasis and atopic dermatitis. It employs non-invasive methods to collect biosamples from patients and utilizes bioinformatics and machine learning to analyze changes in their skin. By developing remote monitoring technologies, the study aims to enhance our understanding of the immune responses in these conditions and facilitate home-based research. Patients will be engaged in a way that allows for real-time tracking of their skin health in relation to environmental exposures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with psoriasis or atopic dermatitis who are interested in monitoring their condition in relation to environmental factors.
Not a fit: Patients with skin conditions unrelated to environmental factors or those who do not have psoriasis or atopic dermatitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management and treatment strategies for patients with skin diseases by identifying environmental triggers.
How similar studies have performed: Previous research has shown promise in using remote monitoring and machine learning approaches to understand skin diseases, indicating that this approach could be effective.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Liao, Wilson — University of California, San Francisco
- Study coordinator: Liao, Wilson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.